The 15th MSA agreement suggests that Biovica has secured well over 20 MSA-based projects.
Mangold uppdaterar sin syn på greentech-bolaget ChargePanel efter det andra kvartalet 2024.
Redeye provides a brief comment on WntResearch’s initial phase 2 data.
Redeye comments on the positive ALG.APV-527 data presented at ESMO this weekend.
Redeye briefly comments on the recent management change in Integrum.
VBG Groups andra kvartal visade på en viss nedgång men bolaget gynnas i nuläget av stark efterfrågan...
Redeye comments on the news about the company’s lower-than-expected number of patients who have achi...
We cut '24e-'26e sales by 5-3% on outlook downgrade Delays should result in pent-up demand Share is ...
Mangold återupptar bevakning på cleantech-bolaget Cortus Energy (Cortus).
Sales ramp-up continues (187% y-o-y), +13% vs. ABGSCe Positive EBIT (SEK 324k vs.
FY'24 org. growth outlook downgraded... ...now expecting 5-10% org.
Redeye comments on the lowered expectations of the primary endpoint in the ongoing phase 3 trial.
Redeye comments on the closing of the financing agreement with Pollen Street, securing SEK600m in in...
Redeye comments on Oncopeptides’ licensing deal for Pepaxti in South Korea.
Biovica records IVD test sales in Q1 of SEK 0.62m, which is 50% above the previous quarter (Q4) and ...
Administer’s recent profitability strides signal a promising turn, with the potential for the new st...
Redeye comments on the recent announcement of Sleep Cycle's partnership with MyFitnessPal, the leadi...
Redeye comments on its latest insights regarding regulatory development in India, partly about the r...
Q-linea has signed S.C. Mecro System SRL as a distributor for Romania, which is part of an attractiv...
Nu är arbetet med att starta guldbrytning i Fäbodtjärn i full gång efter att alla tillstånd är på pl...
